July 15, 2020 News by Forest Ray PhD Vital Neurological Care Missing During Pandemic, UK Survey Finds The ongoing COVID-19 pandemic is disrupting vital care and support for those with neurological disorders like multiple sclerosis (MS), according to a recent report from the Neurological AllianceĀ in the U.K. The report is based upon survey responses from over 1,600 people with neurological conditions in that…
June 26, 2020 News by Marisa Wexler, MS NICE Does Not Favor Adding Mayzent to NHS England for Active SPMS TheĀ National Institute for Health and Care Excellence (NICE) is recommending againstĀ Mayzent (siponimod) as a treatment for active secondary progressive multiple sclerosis (SPMS) in the U.K., because its cost-effectiveness relative to an existing treatment for these patients is not known. NICE’s draft guidance for Mayzent is open…
August 23, 2019 Columns by John Connor Life Is Better with a Local MS Nurse I was struck down by sclerosis in 2006 ā literally. I was playing tennis and ran to return a drop shot. I never made it, but I did drop myself and rupture my right shoulder. It was so severe that it took two operations to rectify. The first few years…
August 19, 2019 News by Marisa Wexler, MS NHS ‘Toolkit’ Aims to Improve Care Given People with MS, Other Neurological Ills in UK The National Health Service (NHS) EnglandĀ announced an initiative that aims to speed diagnoses and ensure better all-around care for people with progressive neurological conditions like multiple sclerosis (MS), Parkinson’s disease, and motor neuron disease (MND). Experts at NHS England, as part of the NHS RightCare…
August 12, 2019 News by Jose Marques Lopes, PhD NICE and NHS England Oppose Sativex to Treat Spasticity in MS, Urge More Studies of Medical Cannabis A draft guidance issued by the National Institute for Health and Care Excellence (NICE), a U.K. advisory board, and a reviewĀ by Englandās National Health Service (NHS) call for more research into medical cannabis forĀ multiple sclerosisĀ and other conditions. NICE also recommended against prescribingĀ SativexĀ as a treatment for…
February 18, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Misdiagnosing MS, Gilenya Relapse Study, Ocrevus in England, Estimate of Americans with MS Doubles Almost 1 in 5 People Wrongly Diagnosed with MS at Two Specialized Centers in US, Study Finds We know that MS is a difficult disease to diagnose, but is it really possible that 20 percent of the MS diagnoses are wrong? Apparently so. This study reports that…
February 11, 2019 News by Jonathan Grinstein Petition Urges NHS England to Make Ocrevus Available for PPMS Patients More than 21,000 people have signed a petition calling for Ocrevus (ocrelizumab) to be made available by the National Health Service (NHS) in England for people with primary progressive multiple sclerosis (PPMS). According to anĀ MS Trust press release, the…